Literature DB >> 6698315

Interrelation of platelet vitamin E and thromboxane synthesis in type I diabetes mellitus.

C W Karpen, S Cataland, T M O'Dorisio, R V Panganamala.   

Abstract

Platelet vitamin E content and thromboxane A2 (TxA2) synthesis have been investigated in type I diabetic subjects and age- and sex-matched controls. Platelets, but not plasma, from diabetic subjects contained significantly lower vitamin E levels and synthesized significantly greater amounts of TxA2 when challenged with collagen or thrombin than platelets from control subjects. Conversion of exogenously added arachidonic acid to TxA2 was unaltered between platelets from control and diabetic groups. Platelet vitamin E content from control and diabetic groups combined exhibited a significant negative linear correlation with collagen- and thrombin-induced TxA2 production. These data suggest that low platelet vitamin E levels could be a contributing factor to the increased thromboxane synthesis demonstrated by platelets from the above type I diabetic subjects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6698315     DOI: 10.2337/diab.33.3.239

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids.

Authors:  H P Hammes; A Weiss; D Führer; H J Krämer; C Papavassilis; F Grimminger
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

2.  In vitro and in vivo effects of selenium and selenium with vitamin E on platelet functions in diabetic rats relationship to platelet sorbitol and fatty acid distribution.

Authors:  C Douillet; M Bost; M Accominotti; F Borson-Chazot; M Ciavatti
Journal:  Biol Trace Elem Res       Date:  1996-12       Impact factor: 3.738

3.  Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulation: possible implications for diabetic atherosclerosis.

Authors:  J V Hunt; M A Bottoms; K Clare; J T Skamarauskas; M J Mitchinson
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

4.  Protective role of oral antioxidant supplementation in ocular surface of diabetic patients.

Authors:  V Peponis; M Papathanasiou; A Kapranou; C Magkou; A Tyligada; A Melidonis; T Drosos; N M Sitaras
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

5.  Vitamin E status in normocholesterolemic and hypercholesterolemic diabetic patients.

Authors:  M G Vandewoude; L F van Gaal; M F Vandewoude; I H De Leeuw
Journal:  Acta Diabetol Lat       Date:  1987 Apr-Jun

Review 6.  Prevention of platelet dysfunction by vitamin E in diabetic atherosclerosis.

Authors:  H Gerster
Journal:  Z Ernahrungswiss       Date:  1993-12

7.  Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries.

Authors:  Asaf A Qureshi; Charles W Karpen; Nilofer Qureshi; Christopher J Papasian; David C Morrison; John D Folts
Journal:  Lipids Health Dis       Date:  2011-04-14       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.